ST14 Antikörper (AA 298-400)
Kurzübersicht für ST14 Antikörper (AA 298-400) (ABIN520529)
Target
Alle ST14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 298-400
-
Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant ST14.
-
Sequenz
- PPSYNLTFHS SQNVLLITLI TNTERRHPGF EATFFQLPRM SSCGGRLRKA QGTFNSPYYP GHYPPNIDCT WNIEVPNNQH VKVRFKFFYL LEPGVPAGTC PKD
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- ST14 (NP_068813, 298 a.a. ~ 400 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
Novel surface targets and serum biomarkers from the ovarian cancer vasculature." in: Cancer biology & therapy, Vol. 12, Issue 3, pp. 169-80, (2011) (PubMed).
: "
-
Novel surface targets and serum biomarkers from the ovarian cancer vasculature." in: Cancer biology & therapy, Vol. 12, Issue 3, pp. 169-80, (2011) (PubMed).
-
- ST14 (Suppression of Tumorigenicity 14 (ST14))
-
Andere Bezeichnung
- ST14
-
Hintergrund
-
Full Gene Name: suppression of tumorigenicity 14 (colon carcinoma)
Synonyms: HAI,MT-SP1,MTSP-1,MTSP1,PRSS14,SNC19,TADG-15 -
Gen-ID
- 6768
-
NCBI Accession
- NM_021978
Target
-